DRUGS recently approved around the world to fight cancer increased patients' overall survival, but benefits vary depending on the drug, a new study shows.
Researchers looked at the 62 cancer drugs approved in the U.S. and Europe between 2003 and 2013 and found they extended survival by an average of about 3.5 months.
But nearly a third of the drugs lacked evidence to suggest they increased survival when compared to alternative treatments.
"Our results point to the notion that new cancer treatments may not always provide patients with greater clinical benefits, or lower risks, over existing treatments," wrote senior researcher Dr. Elias Mossialos, of the London School of Economics and Political Science, in an email to Reuters Health.
The risk-benefit ratio of new drugs is especially important if people are concerned, for example, about whether the cost of a drug would make it difficult for a person to complete the treatment regimen.
Writing in JAMA Oncology, Mossialos and colleagues point to growing questions about the value of new cancer medicines. While the drugs' high costs may be a barrier to access, they note, some people argue the high prices are justified if the treatments offer large benefits.
A lack of solid data on new drugs' benefits and risks makes it difficult to evaluating their value.
For the 62 medicines they wanted to study, the researchers found data from England, France and Australia evaluating 53 drugs. Nearly 80 percent were tied to improvements in survival, quality of life or safety.
The drugs increased survival - with or without recurrence - by about 3.5 months on average, compared to other treatments available in 2003.
Twenty-three drugs were individually tied to an increase in survival of three months or more. Six drugs extended survival by less than three months. Eight drugs increased survival by an unknown amount. And for 16 of the approved drugs, there was no evidence to suggest they were better than alternative treatments at extending survival.
The researchers point out in an email that overall survival benefits differed by the type of drug. For example, drugs for thyroid cancer were tied to no increase in overall survival, while drugs to treat breast cancer were linked to an average increase of about 8.5 months.
Twenty-two of the drugs were tied to an improved quality of life, but 24 were linked to worse patient safety, which include side effects and whether a person could tolerate the treatment.
The researchers write in their email that they extending the study to look at newer drugs. They are also working to link their evidence with the cost of individual medicines.
Mossialos said the study should remind people of the importance of the relationship between doctors and patients. He said, "Patients should work with their physicians to consider all available evidence that exists in support of individual treatments, and use this alongside any inputs from their clinician to identify the treatment that would best correspond with their own medical and personal circumstances."
Reuters
Tue Jan 03 2017
The drugs increased survival - with or without recurrence - by about 3.5 months on average, compared to other treatments available in 2003. - Photo for illustration purpose only
Hospital UMS bakal beroperasi pada tahun 2026
Hospital Universiti Malaysia Sabah (HUMS) yang sedang dalam proses pembinaan bakal beroperasi pada bulan Januari 2026
LLB beri amaran jangan hampiri pantai, R&R Bagan Ajam
Berikutan kejadian yang berlaku pada tengah hari Selasa, pihak Lebuhraya Lingkaran Luar Butterworth (LLB) memberi amaran kepada orang ramai agar tidak menghampiri kawasan pantai di situ kerana cuaca yang sangat tidak baik dan keadaan ombak yang tinggi.
Hujan lebat: Rakyat Perlis dinasihatkan berwaspada - MB
Hujan lebat disusuli angin kencang melanda beberapa kawasan sekitar Perlis pada Selasa menyebabkan pokok tumbang, selain gangguan bekalan elektrik.
Jumlah mangsa banjir melebihi 2,000 orang, 11 PPS dibuka
Situasi banjir di Kedah makin memburuk selepas bilangan mangsa mencecah 2,180 orang mangsa daripada 385 keluarga yang ditempatkan di 11 pusat pemindahan sementara (PPS).
Ahli GISB dituduh di Mahkamah Putrajaya pada Rabu
Berdasarkan pemakluman kepada media, individu terbabit akan didakwa di bawah Seksyen 506 Kanun Keseksaan di Mahkamah Putrajaya pada Rabu.
Melaka dalam proses wartakan lima lagi ajaran sebagai sesat
Kerajaan Melaka dalam proses mewartakan lima lagi ajaran dan kegiatan baharu sebagai sesat.
PRK Mahkota: Syed Hussien enggan tabur janji bulan dan bintang, ingin kekal semangat kekeluargaan
Syed Hussien berazam ingin terus mengekalkan semangat kekeluargaan yang dinikmati penduduk di DUN Mahkota.
Meteorit Marikh ditemukan di Antartika dipamerkan di Ekspo Osaka 2025
Ditemukan pada 2000, meteorit itu telah tercampak ke angkasa lepas akibat kesan asteroid di permukaan Marikh.
Perang di Gaza perlu dihentikan, tiada pendudukan semula Israel - Kamala Harris
Calon Presiden AS gesa gencatan senjata serta penyelesaian dua negara dan kestabilan Asia Barat dengan cara yang tidak memperkasakan Iran.
Malaysia-Brazil bekerjasama rebut peluang pasaran halal bernilai AS$3 trilion - Timbalan Menteri
Transaksi pertanian antara kedua-dua negara telah berada dalam aliran menaik sehingga mencecah RM6.4 bilion pada 2023.
Memerangi kanser payudara ketika pandemik COVID-19
Kebanyakan kanser payudara bermula dari sel yang melapisi bahagian saluran (ductal cancer), sebahagian lain bermula pada kelenjar lobul (lobular cancer) dan selebihnya bermula dari tisu-tisu lain.
Pesakit kanser cabar diri sendiri terima kad Krismas dari seluruh Amerika
Ternyata dengan kuasa media sosial, Ryan menerima 3000 kad daripada kesemua 50 negeri di Amerika Syarikat dan 29 negara.
Angelina Jolie umum buang ovari bimbang terjadi kanser
Angelina Jolie hari ini mengumumkan bahawa beliau telah menjalani pembedahan membuang ovari dan tiub fallopio dua tahun lepas.